Martin Jädersten

机构：Karolinska University Hospital, Karolinska Institutet · ORCID：0000-0001-5217-3235

发表论文 141 篇 · 总被引 6275 次 · h-index 33

代表论文

• Precision oncology to overcome resistance in R/R AML in children and adults requires combinations of cytotoxic, targeted, and immunological treatments (2025 · Journal of Internal Medicine · 被引 7)
• Maintenance therapy with the FMS‐like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS‐like tyrosine kinase 3–internal tandem duplication acute myeloid leukemia: A phase 2 study (2025 · Cancer · 被引 5)
• Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study (2025 · Clinical Cancer Research · 被引 4)
• Development of myeloid neoplasia associated with prolonged immune cell‐associated hematotoxicity after CAR T‐cell treatment of B‐cell lymphoma: Should we surveille for pre‐existing myeloid mutations? (2025 · HemaSphere · 被引 2)
• Influence of Cytogenetics on the Outcome of Patients With High‐Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide (2025 · Genes Chromosomes and Cancer · 被引 2)
• Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia (2026 · Nature · 被引 1)